AMARIN CORP PLC\UK Unrecognized Tax Benefits that Would Impact Effective Tax Rate
AMARIN CORP PLC\UK (AMRN) had Unrecognized Tax Benefits that Would Impact Effective Tax Rate of $10.80 million as of 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate · last filed 2026-03-02
- 2025-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $10.80M.
- 2024-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $11.70M.
- 2023-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $8.90M.
- 2022-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $8.20M.
| Period end | Unrecognized Tax Benefits that Would Impact Effective Tax Rate |
|---|---|
| 2025-12-31 | $10.80M 10-K · filed 2026-03-02 |
| 2024-12-31 | $11.70M 10-K · filed 2026-03-02 |
| 2023-12-31 | $8.90M 10-K · filed 2025-03-12 |
| 2022-12-31 | $8.20M 10-K · filed 2024-02-29 |
| 2021-12-31 | $7.90M 10-K · filed 2023-03-01 |
| 2020-12-31 | $5.60M 10-K · filed 2022-03-01 |
| 2019-12-31 | $0.00 10-K · filed 2021-02-25 |
| 2018-12-31 | $0.00 10-K · filed 2020-02-25 |
| 2017-12-31 | $0.00 10-K · filed 2019-02-27 |
| 2016-12-31 | $1.50M 10-K · filed 2018-02-27 |
| 2015-12-31 | $1.40M 10-K · filed 2017-03-01 |
| 2014-12-31 | $1.40M 10-K · filed 2016-02-25 |
| 2013-12-31 | $1.70M 10-K · filed 2015-03-03 |
| 2012-12-31 | $1.20M 10-K · filed 2014-02-27 |
| 2011-12-31 | $1.00M 10-K · filed 2013-02-28 |
| 2010-12-31 | $500.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |